Document is current
Any future updates will be listed below
-
Authors
Faiz, Mifra https://orcid.org/0000-0001-8681-6286
Riedemann, Merle https://orcid.org/0009-0004-5457-7451
Jutzi, Jonas S. https://orcid.org/0000-0002-1977-153X
Mullally, Ann https://orcid.org/0000-0001-9727-8495
-
Funding
Funding for this research was provided by:
NIH NHLBI (R01HL131835)
Department of Defense Congressionally Directed Medical Research Program (W81XWH2110909)
Leukemia & Lymphoma Society ((LLS Discovery Grant ID: 8041-24)
Starr Cancer Consortium
- License Information
-
More Information
Article History
Accepted: 23 December 2024
First Online: 8 January 2025
Declarations
:
: In the last 24 months, AM has received research funding from Relay and Morphic and consulted for Morphic, BioMarin, Protagonist, Incyte, Nuvalent, PharmaEssentia and Cellarity.
